Cardinal Health, Inc.
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
What does it do?
Cardinal Health is essentially the behind-the-scenes delivery network for the American healthcare system. When a hospital needs thousands of doses of a medication, or a pharmacy needs to restock its shelves, Cardinal Health is often the company making that happen. They move branded drugs, generic drugs, and medical supplies from manufacturers to the places that actually use them — think of them as the Amazon fulfillment center, but for medicine. They serve over 90% of U.S. hospitals and tens of thousands of pharmacies, so their reach is massive even if most people have never heard of them.
Cardinal Health sits at the center of a $600B+ pharmaceutical distribution market that cannot be easily disrupted — hospitals and pharmacies have deeply embedded contracts and switching costs that make this an incredibly sticky business. With an aging U.S. population driving more drug prescriptions and medical procedures every year, the volume flowing through Cardinal's network is structurally growing. Investors are also watching closely as the company pivots toward higher-margin specialty pharmaceuticals, like cancer drugs and biologics, which could meaningfully improve profitability.
How does it make money?
Cardinal Health makes money in two main ways. The larger piece is its Pharmaceutical and Specialty Solutions segment, which earns a thin margin — often fractions of a cent per dollar — on moving enormous volumes of drugs, generating the bulk of that $222.6B in revenue. The second segment, Global Medical Products and Distribution, manufactures and sells items like surgical gloves, gowns, and lab supplies directly to hospitals, which carries better profit margins. Because the drug distribution business runs on razor-thin margins, the company needs massive scale to be profitable, and its $222.6B revenue versus $1.6B net income reflects exactly that dynamic.
Why do investors care?
The core investment case is that Cardinal Health is a toll booth on the U.S. drug supply chain — volume keeps growing as Americans fill more prescriptions, and Cardinal collects a small fee on every transaction. The more exciting growth story is specialty pharmaceuticals: drugs for complex conditions like cancer or rare diseases are growing faster and carry higher fees than standard medications. For the thesis to work, Cardinal needs to keep winning specialty drug distribution contracts and improve margins in its medical products business, which has been a drag in recent years due to supply chain costs.
Deep Dive
MemberA full investor briefing on Cardinal Health, Inc. — history, leadership, risks, and outlook.